MAFLD: What Is It?

Houston Methodist

D. Victor

Best Practices In Managing NAFLD / NASH

MedNews Week

D. Bernstein

Liver Fat, Iron, Fibrosis, (and T1): Quantitative MRI in Chronic Liv…

UCSF School of Medicine

M. A. Ohliger

The Fatty Liver Disease Epidemic

UPMC

M. Klinge

Alcoholism is a Mid-brain Disease: Treat it as Such

Houston Methodist

H. Wetsman

Long Term Management of Liver Transplant Recipients

UCLA Health

G. Choi

Round Table: Pre- and Post- Transplant Complications

Rush University Medical Center

C. Aloman, L. Brown, S. Janardhan

Using Resmetirom (THR-β Agonist) in Your Practice for MASH

Scripps Health

J. Gutierrez

Current Treatment of Metabolic Dysfunction Associated with Steatotic…

Indiana University School of Medicine Division of Gastroenterology and Hepatology

N. Samala

Caring for the Post Liver Transplant Patient in the Primary Care Set…

University of Colorado Department of Medicine

B. Henderson, M. O'Meara

Cutting Edge Diagnostics and Treatment for NAFLD

Northwestern Medicine Gastroenterology

M. E. Rinella, L. Van Wagner

Evaluating Liver-Related Mortality and Liver Transplant Outcomes

Stanford Medicine

W. Ray Kim

The Evolving Landscape of Non-Alcoholic Fatty Liver Disease (NAFLD) …

Cardiometabolic Health Congress (CMHC)

K. Cusi

Heart and Liver Interactions

Houston Methodist DeBakey Heart and Vascular Center

S. Adeel Ahsan

Fatty Liver Disease: When to Refer?

Yale School of Medicine

Cases in Portal Hypertension Management

Northwestern Medicine Gastroenterology

J. Boike, C. Moore, S. Koppe, R. Salem, S. Thaker

NASH Update 2023

Icahn School of Medicine at Mount Sinai

M. B. Bansal

NAFLD: Updates in Management

UChicago Medicine

M. E. Rinella

Updates on Management of NASH

Pennsylvania Society of Gastroenterology

T. Singh

Non-Alcoholic Fatty Liver Disease: Where Are We in 2023?

Houston Methodist

N. Gunn